Max Borsche from the Institute of Neurogenetics and Department of Neurology received ~300.000€ from the Else Kröner-Fresenius-Stifung (EKFS) to conduct a longitudinal investigation of inflammatory markers and alpha-synuclein pathology in (monogenic) Parkinson’s disease.